Recombinant angiopoietin-like protein 4 attenuates intestinal barrier structure and function injury after ischemia/reperfusion

Figure 9 Levels of VE-cadherin after hypoxia/reoxygenation compared with respective vehicle cells. Recombinant human angiopoietin-like protein 4 restored the VE-cadherin (VE-cad) in human umbilical vein endothelial cells (A) after hypoxia/reoxygenation and VE-cadherin levels in small interfering (si) RNA angiopoietin-like protein 4 control and small interfering RNA angiopoietin-like protein 4 (ANGPLT4) human umbilical vein endothelial cells (B) of different groups (mean ± SD, n = 3). ^bP < 0.01 vs vehicle; ^dP < 0.01 vs vehicle. H/R: Hypoxia/reoxygenation.